Literature DB >> 4840449

Cephradine: absorption, excretion, and tissue distribution in animals of a new cephalosporin antibiotic.

I Weliky, H H Gadebusch, K Kripalani, P Arnow, E C Schreiber.   

Abstract

Metabolic studies were conducted with cephradine administred by the oral, subcutaneous, intravenous, or rectal routes to mice, rats, and dogs. Peak blood levels were usually attained in 30 to 150 min after dosing, depending on the animal species studied. Based on urinary excretion, cephradine appeared to be well absorbed after oral or subcutaneous administration; after rectal doses, cephradine was absorbed poorly. In rats and dogs given oral or intravenous doses of cephradine, about 70 to 100% of the administered dose was recovered during a 24-h collection period. Cephradine was excreted unchanged. After the oral or intravenous administration of [(3)H]cephradine to rats and dogs, respectively, its plasma half-life was about 1 h. After oral administration to rats, cephradine was distributed widely throughout the body tissues, with the greatest concentrations in the kidneys and liver; at 45 min to 6 h postdose, cephradine concentrations in the kidneys and liver were about 8 and 3 times higher, respectively, than those in plasma.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4840449      PMCID: PMC428917          DOI: 10.1128/AAC.5.1.49

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  A new class of semisynthetic penicillins and cephalosporins derived from D-2-(1,4-cyclohexadienyl)glycine.

Authors:  J E Dolfini; H E Applegate; G Bach; H Basch; J Bernstein; J Schwartz; F L Weisenborn
Journal:  J Med Chem       Date:  1971-02       Impact factor: 7.446

2.  Cephradine in the treatment of intestinal infections caused by Shigella or Salmonella organisms.

Authors:  L Landa
Journal:  Curr Ther Res Clin Exp       Date:  1972-08

3.  A new cephalosporin derivative, cephradine (TM) , in the treatment of acute infective diseases.

Authors:  B M Limson; R E Siasoco; F P Dial
Journal:  Curr Ther Res Clin Exp       Date:  1972-03

4.  Toxicological, pathological, and teratological studies in animals with cephradine.

Authors:  G L Hassert; P J DeBaecke; J S Kulesza; V M Traina; D P Sinha; E Bernal
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

  4 in total
  3 in total

1.  Pharmacokinetic interpretation of cephradine levels in serum after intravenous and extravascular administration in humans.

Authors:  E S Rattie; P D Bernardo; J J Ravin
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

2.  Fluorimetric assay of cephradine, cephalexin and cephaloglycin.

Authors:  R H Barbhaiya; P Turner
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

3.  Development and validation of a UPLC-MS/MS method to monitor cephapirin excretion in dairy cows following intramammary infusion.

Authors:  Partha Ray; Katharine F Knowlton; Chao Shang; Kang Xia
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.